RecruitingNCT06917339
Retrospective Analyses of TrakStar Database
Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes
Sponsor
Neuronetics
Enrollment
156,000 participants
Start Date
Feb 25, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Eligibility
Min Age: 5 YearsMax Age: 120 Years
Inclusion Criteria3
- Male or female reported in database and not an invalid entry
- Age reported and not an invalid entry
- Treatment date of November 01, 2008 or later.
Exclusion Criteria1
- • Incomplete information on treatment parameters
Interventions
DEVICENeuroStar Advanced TMS Therapy System
non-invasive brain stimulation device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06917339
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT073648253 locations
A Multicenter Pediatric Deep Brain Stimulation Registry
NCT065856181 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms
NCT074694621 location